Augustine v. Arizant Inc.

751 N.W.2d 95, 2008 Minn. LEXIS 313, 2008 WL 2520834
CourtSupreme Court of Minnesota
DecidedJune 26, 2008
DocketA06-12381
StatusPublished
Cited by3 cases

This text of 751 N.W.2d 95 (Augustine v. Arizant Inc.) is published on Counsel Stack Legal Research, covering Supreme Court of Minnesota primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Augustine v. Arizant Inc., 751 N.W.2d 95, 2008 Minn. LEXIS 313, 2008 WL 2520834 (Mich. 2008).

Opinion

OPINION

ANDERSON, G. BARRY, Justice.

Appellant Scott D. Augustine, M.D., founder and former officer of respondent Augustine Medical, Inc., pleaded guilty to a misdemeanor violation of 42 U.S.C. § 1320a-7b(a)(2) (2000) and 18 U.S.C. § 2 (2000). Appellant sought indemnification for his fine and attorney fees from respondent Arizant, Inc., Augustine Medical’s parent company. Arizant refused appellant’s indemnification request, and appellant commenced this action seeking indemnification pursuant to Minn.Stat. § 302A.521 (2006) and the terms of the parties’ separation and release agreement. The jury returned a verdict in appellant’s favor. The court of appeals reversed appellant’s indemnification award, concluding that the district court erred in denying respondents’ motion for summary judgment because appellant’s conviction and sworn admissions conclusively established that he did not act in good faith. Augustine v. Arizant Inc., 735 N.W.2d 740, 744-46 (Minn.App.2007). We reverse the decision of the court of appeals and remand for further proceedings.

Appellant is an anesthesiologist and inventor who founded respondent Augustine Medical, Inc., in 1987 and served as the company’s CEO and chairman of the board. 1 He invented a product known as ‘Warm-Up Active Wound Therapy” for the treatment of chronic wounds. Because Warm-Up is typically administered in nursing homes, outpatient rehabilitation facilities, and home healthcare settings, all of which are heavily dependent on Medi *97 care reimbursement, Augustine Medical considered Warm-Up’s eligibility for Medicare coverage to be an important issue. Appellant testified that the initial determination regarding whether a claim will be reimbursed by Medicare is made by a “fiscal intermediary,” a private insurance company that contracts with Medicare to handle claims for a particular region. According to appellant, a reimbursement claim for an item may be submitted even if a fiscal intermediary has denied coverage, and such claims are often paid on appeal. Augustine Medical received advice regarding Medicare reimbursement for WarmUp from director of reimbursement Paul Johnson, in-house counsel Randy Benham, outside Medicare consultant Phillip Zarlen-go, and the law firms of Oppenheimer Wolff & Donnelly LLP and Vinson & El-kins LLP.

In November 1999, Augustine Medical learned that TriSpan Health Services, a fiscal intermediary, had determined that Warm-Up would not be reimbursed by Medicare. Appellant and other Augustine Medical representatives made a Warm-Up presentation to TriSpan in January 2000, and TriSpan subsequently reversed field and notified Augustine Medical that Warm-Up would be reimbursed by Medicare. But, on June 27, 2000, appellant received a letter from TriSpan that read as follows: “After careful review of your submitted brochures and monographs and a literature review, we have decided that the Warm-Up’ therapy is investigational at this time. We will review the topic as additional studies warrant.” Appellant understood the term “investigational” to refer to devices that have not been approved for marketing by the Food and Drug Administration (FDA). Because the FDA had approved the marketing of Warm-Up in 1997, appellant and others at Augustine Medical were confused by the TriSpan letter.

In e-mails to his colleagues at Augustine Medical, Paul Johnson explained that the TriSpan “letter is a total about face from every verbal communication I have had with three different TriSpan representatives” and that the “letter strongly implies TriSpan will not cover Warm-Up therapy.” Appellant testified that “eventually, we just decided that [the letter] was wrong, and we shouldn’t hand it out.” According to appellant, “We were billing Medicare claim by claim before the letter. And when we didn’t get coverage, we were billing Medicare claim by claim after the letter. So I didn’t see [that] it had any [e]ffect on the rules.”

Augustine Medical personnel learned in July 2000 that Tri-Span had denied reimbursement claims for Warm-Up. In an email to appellant and others at Augustine Medical, Randy Benham cautioned “that we should not assume that TriSpan has decided not to reimburse for Warm-Up. Let’s begin with the assumption that [the author of the TriSpan letter] merely informed us that TriSpan has refused to issue a local rule mandating reimbursement.” Benham testified, however, that he advised the company that customers known to be billing TriSpan should be notified that TriSpan was denying reimbursement claims for Warm-Up.

Southern Medical Distributors, which was part of a government “sting” operation created to uncover Medicare fraud, had ordered Warm-Up from Augustine Medical. Tim Hensley, Augustine Medical’s national sales manager, met with representatives of Southern Medical in Atlanta on August 16, 2000, but he did not disclose the TriSpan letter. In a telephone conversation 6 days later, Hensley told a Southern Medical representative that Augustine Medical did not have anything in writing from TriSpan. Appellant *98 testified that he also spoke with Southern Medical on several occasions and that, when Southern Medical asked him about TriSpan, he explained that TriSpan had denied coverage for Warm-Up. Indeed, in a telephone conversation with a Southern Medical representative on January 22, 2001, appellant stated that TriSpan had deemed Warm-Up investigational and had decided not to cover the product. Appellant reiterated to Southern Medical on March 1 that TriSpan had denied coverage for Warm-Up.

Appellant’s relationship with other members of the board of directors soured, and he resigned as an employee of the company on December 31, 2002. In 2003, appellant, Paul Johnson, Randy Benham, Tim Hensley, Phillip Zarlengo, Arizant, and Augustine Medical were indicted for the felonies of conspiracy to defraud the United States, healthcare fraud, and mail fraud in connection with obtaining Medicare reimbursement for Warm-Up. Augustine Medical pleaded guilty to the felony of conspiracy to defraud the United States in violation of 18 U.S.C. § 371 (2000) and was ordered to pay a criminal fine exceeding $5 million and a civil fine exceeding $7 million. Appellant’s trial was expected to last 3 to 4 months, but about 7 weeks into trial the government offered to dismiss the felony charges against appellant if he would plead guilty to a misdemeanor. 2 On June 29, 2004, appellant pleaded guilty to “knowingly and willfully aid[ing] and abett[ing] others in causing to be withheld from Southern Medical Distributors a material fact for use in determining rights to benefits and payments under * * * the Medicare program” in violation of 42 U.S.C. § 1320a-7b(a)(2) 3 and 18 U.S.C. § 2.

Related

Sampair v. Village of Birchwood
784 N.W.2d 65 (Supreme Court of Minnesota, 2010)
Thomas B. Olson & Associates, P.A. v. Leffert, Jay & Polglaze, P.A.
756 N.W.2d 907 (Court of Appeals of Minnesota, 2008)

Cite This Page — Counsel Stack

Bluebook (online)
751 N.W.2d 95, 2008 Minn. LEXIS 313, 2008 WL 2520834, Counsel Stack Legal Research, https://law.counselstack.com/opinion/augustine-v-arizant-inc-minn-2008.